Exiqon A/S Release: Interim Report For The Period 1 January - 31 March 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

First quarter highlights include 18% growth in North American sales, 20% increase in gross profit, positive EBIT of DKK 0.5 million and first ever reported positive Earnings Per Share of DKK 0.02.

Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced results for the first quarter of 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news